This is just a quick reminder of two upcoming conferences from ACI that should be of interest to Orange Book Blog readers: "Paragraph IV Disputes" and the "3rd Annual In-House Counsel Forum on Pharmaceutical Antitrust."
"Paragraph IV Disputes," to be held April 23-24 in New York, will offer "expert insights on Hatch-Waxman litigation strategies for brand names and generics." Several of the panels will touch on the Norvasc case (FDA decision expected this Wednesday!), including its pediatric and 180-day exclusivity issues.
The "3rd Annual In-House Counsel Forum on Pharmaceutical Antitrust," to be held May 15-16 in New York, features addresses by FTC Chairman Majoras, Assistant AG Barnett, and nine other federal and state enforcement officials. The Tamoxifen case in the Supreme Court and the pending legislation to ban "reverse payment" settlements will be hot topics of discussion.
For more information or to register, click the links above. When registering, use discount code 710OBB to receive $200 off tuition.
Orange Book Blog is a media sponsor of these conferences.
Orange Book Blog 
Leave a comment